CryoPort

Update in progress

CYRX (NasdaqCM)

Company RatingNeutral
SectorIndustrials
IndustryIntegrated Freight & Logistics

Cryoport, Inc. provides temperature-controlled supply chain solutions for biopharma, animal health, and reproductive medicine worldwide. It offers Life Sciences Services for logistics, biostorage, bioservices, cryopreservation, and sample management; and Life Sciences Products, selling cryogenic freezers, dewars, shippers, and related accessories via direct sales or a distribution network. It also delivers Cryoport BioStorage, IntegriCell services, Cryoport consulting, and MVE cryogenic systems, plus monitoring and transport of frozen biological specimens. Founded in 1999, based in Brentwood, Tennessee.

Company score

Sentiment: 0.32; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive